相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau et al.
IMMUNOLOGY (2013)
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
Fanny Chalmin et al.
IMMUNITY (2012)
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
Fabian Benencia et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
What are regulatory T cells (Treg) regulating in cancer and why?
Theresa L. Whiteside
SEMINARS IN CANCER BIOLOGY (2012)
Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
Francois Martin et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
2011: the immune hallmarks of cancer
Federica Cavallo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
Sylvain Ladoire et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
Marie Tosolini et al.
CANCER RESEARCH (2011)
Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function
Jian Ye et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Distribution and Clinical Significance of Th17 Cells in the Tumor Microenvironment and Peripheral Blood of Pancreatic Cancer Patients
Songbing He et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Yi-Lan Zhang et al.
MOLECULAR CANCER (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors
Danila Valmori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Plasticity of CD4+ T Cell Lineage Differentiation
Liang Zhou et al.
IMMUNITY (2009)
Late Developmental Plasticity in the T Helper 17 Lineage
Yun Kyung Lee et al.
IMMUNITY (2009)
Role of macrophages in tumour progression
K. S. Siveen et al.
IMMUNOLOGY LETTERS (2009)
Alternatively activated macrophages in infection and autoimmunity
DeLisa Fairweather et al.
JOURNAL OF AUTOIMMUNITY (2009)
FOXP3 Expression and Overall Survival in Breast Cancer
Andrea Merlo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increased intratumoral IL-17-producing cells survival in hepatocellular carcinoma correlate with poor patients
Jing-Ping Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression
Magis Mandapathil et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Epigenetic control of T-helper-cell differentiation
Christopher B. Wilson et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Hans J. P. M. Koenen et al.
BLOOD (2008)
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio:: Which variable determines survival of cervical cancer patients?
Ekaterina S. Jordanova et al.
CLINICAL CANCER RESEARCH (2008)
Tumor versus tumor-associated macrophages: How hot is the link?
C. Guruvayoorappan
INTEGRATIVE CANCER THERAPIES (2008)
IL-21 and TGF-β are required for differentiation of human TH17 cells
Li Yang et al.
NATURE (2008)
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer
Yoshihiro Miyahara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation -mediated apoptosis of effector CD4+ T cells
Pushpa Pandiyan et al.
NATURE IMMUNOLOGY (2007)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Rapid suppression of cytokine transcription in human CD4+CD25- T cells by CD4+Foxp3+ regulatory T cells:: Independence of IL-2 consumption, TGF-β, and various inhibitors of TCR signaling
Nina Oberle et al.
JOURNAL OF IMMUNOLOGY (2007)
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma
Christoph Bergmann et al.
CANCER RESEARCH (2007)
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells:: hydrolysis of extracellular ATP and immune suppression
Giovanna Borsellino et al.
BLOOD (2007)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model
Kutlu G. Elpek et al.
JOURNAL OF IMMUNOLOGY (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Naturally occurring regulatory T cells: Recent insights in health and disease
Giorgio Raimondi et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2007)
Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage INSCLC patients
Rebecca P. Petersen et al.
CANCER (2006)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Giovanna Gallina et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
C Orabona et al.
BLOOD (2006)
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers
C Badoual et al.
CLINICAL CANCER RESEARCH (2006)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Tumor microenvironments, the immune system and cancer survival
RL Strausberg
GENOME BIOLOGY (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Transformation of the microvascular system during multistage tumorigenesis
E Ryschich et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Tumor-induced death of immune cells: its mechanisms and consequences
TL Whiteside
SEMINARS IN CANCER BIOLOGY (2002)
Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors
K Kawamura et al.
CANCER GENE THERAPY (2002)
Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes
XM Zhang et al.
MELANOMA RESEARCH (2001)
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient
LM Real et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
分享论文
